A meta-analysis suggests that delaying chemotherapy in patients with asymptomatic, advanced cancer does not worsen overall survival.

All articles by Leah Lawrence
Atezolizumab, given with or without radiotherapy, has demonstrated some activity in a subset of patients with penile cancer.
Starting treatment for advanced NSCLC before receiving genomic test results compromises patient outcomes, a study suggests.
After 3 or 4 doses, mRNA-based COVID-19 vaccines are similarly effective in patients with cancer and the general population, a study suggests.
Phase 3 trial results support atezolizumab as a potential first-line treatment option for patients with advanced non-small cell lung cancer.
Patients aged 65 years or older are underrepresented in clinical trials supporting cancer drug approvals, a study suggests.
Researchers say they have identified an unintended effect of Medicare’s 340B Drug Pricing Program; increases in spending for outpatient cancer treatments among patients with commercial insurance.
Researchers looked at the use of 6 biosimilars across 38 oncology practices and found that biosimilar use increased from 2019 to 2021.
Pembrolizumab plus ICE chemotherapy appears effective as second-line treatment in patients with transplant-eligible Hodgkin lymphoma.
Low-dose tamoxifen reduces the risk of breast cancer among patients with intraepithelial neoplasia for several years, data suggest.
-
Latest News Your top articles for Thursday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses